Media (also see Latest News)

June 16th, 2010

Innate Therapeutic's talks about Fast Forward LLC

View the talk at the Fast Forward web site, or on YouTube ...


May 5th, 2010
Innate Therapeutics Receives Funding for Clinical Trial
of Progressive Multiple Sclerosis Therapeutic
BusinessWire

Innate Therapeutics today announced funding support from Fast Forward, LLC, a not-for-profit organization established by the U.S. National Multiple Sclerosis Society and EMD Serono, an affiliate of Merck KGaA, Darmstadt, Germany.

Read the full press release here ...

See related annoucement by EMD Serono, Inc and Fast Forward, LLC here ...


October 15th, 2009

TV3 (New Zealand) Business Show interview with Innate Therapeutic's CEO, Simon Wilkinson

View the broadcast interview here ...


April 21st, 2009
Innate Therapeutics’ Novel Microparticle Immune Response Modifier Shows
Broad Spectrum Effects Against Recurrent Cancer or Metastatic Disease.
BusinessWire

Innate Therapeutics’ novel microparticle immune response modifier shows broad spectrum effects against recurrent cancer or metastatic disease. Preclinical data presented at AACR show MIS416 single agent activity, synergistic anti-cancer effects with radiation.
 
Read the full story here ...


April 18th, 2009
Virionyx Changes Name to Innate Therapeutics,
Advances Novel Immune Stimulant, MIS416, to Clinical Trials
BusinessWire

Virionyx Corporation Limited, a New Zealand unlisted public biotechnology company, today announced that it has changed its name to Innate Therapeutics Limited. The new name reflects a major repositioning of the company to focus development activities on its proprietary drug candidate MIS416.

Read the full story here ....


January 2009
The Therapeutic Vaccine Potential of MIS416 Adjuvant
BioPharm International

Linking innate and adaptive immunity through the activation of multiple innate host defenses.

Read the full article here ...


August 2008
Executive Summary - Virionyx: Partnering with the immune system to fight a range of diseases
Specialty Pharma Vol 8 No 7

Virionyx is a New Zealand-based company with two distinct and unusual drug development platforms. The Company has a novel microparticle stimulator (MIS), which is a late-stage, preclinical candidate for programs in oncology, infectious disease, autoimmunity, and vaccine development.

Read the full story here ...


July 7th 2008
Pimple particles in vaccine drive
Chemistry & Industry

An immune-boosting micro-particle derived from the bacteria that cause acne could prove to be a powerful new weapon against diseases from cancer to pandemic flu.

Read the full story here ...


June 2nd 2008
New flu medicine may also fight HIV and hepatitis
TV3 News

With the flu season upon us an Auckland company is developing an antiviral agent that uses the body's immune system for fight disease. In a pandemic situation, it has the potential to protect workers at the front line and the public. These scientists are working on "MIS416" - a tiny micro-particle that's big news in medical circles.

Read the full story here ...

OR stream the video here ...


May 15th 2008
Novel Microparticle Offers Immunological Breakthrough Against a Range of
Infectious Diseases and Potentially Some Cancers
BusinessWire

Virionyx Discovers Proprietary Adjuvant Also Possesses Single Agent Activity

Read the full story here ....


October 27th 2003
Chinese President & New Zealand Prime Minister visit ground-breaking biotech company

While the rest of New Zealand had the day off work to mark Labour Day, the President of China, Mr Hu Jintao, and the Prime Minister of New Zealand, the Right Honourable Helen Clark, visited the Auckland-based laboratories of Virionyx Corporation to discuss infectious diseases and possible bio-terrorist threats such as Anthrax.

Read the full press release here.....  View images .....


August 1st 2003
Prime Minister opens Virionyx's new research facility

The Prime Minister, the Right Honourable Helen Clark, officially opened the new Virionyx Corporation office and laboratory facility in Manukau City, in the presence of His Worship the Mayor Sir Barry Curtis, Virionyx Shareholders and other VIPs including the Mangere Minister of Parliament Mr Taito Phillip Field and American Consulate representative Ms Laura Selby.

Read the full press release here.....  View images .....